cabotamig (ARB202) / Arbele 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cabotamig (ARB202) / Arbele
NCT05411133: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Recruiting
1
68
RoW
Cabotamig (ARB202)
Arbele Pty Ltd
Gastrointestinal Cancer, Cholangiocarcinoma, Liver Cancer, Colorectal Adenocarcinoma, Pancreatic Cancer, Gastric Cancer, Esophageal Adenocarcinoma, Gastroesophageal Junction
11/24
08/25

Download Options